BN Business News
Add your company to Business Communicator →

Business · 12/07/2018Updated: 10/17/2026 · 1 min read

FDA Renews Psychopharmacologic Drugs Advisory Committee for 2 Years

Summary

The FDA has renewed the Psychopharmacologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on June 4, 2020.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →